These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22339959)

  • 21. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
    N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary study of HLA haplotype matched and T-cell undepleted allogeneic bone marrow transplantation for treatment of leukemia].
    Ji S; Chen H; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):408-10. PubMed ID: 11718090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful unmanipulated peripheral blood progenitor cell transplantation from an HLA haploidentical 2-locus-mismatched mother in a thalassemic patient with primary graft failure after transplantation of bone marrow and cord blood from unrelated donors.
    Jaing TH; Sun CF; Lee WI; Wen YC; Yang CP; Hung IJ
    Pediatr Transplant; 2008 Mar; 12(2):232-4. PubMed ID: 18307674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
    Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
    Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of immunological reconstitution and related complications after HLA-matched and HLA haploidentical peripheral blood hematopoietic stem cell transplantation].
    Li L; Yuan HL; Wen BZ; Zhong D; Qu JH; Jiang M; Halida Y; Guo XH; Hao JP
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):204-7. PubMed ID: 20450650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hematopoietic stem cell transplantation for beta-thalassemia major].
    Zhu W; Yang M; He Y
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):265-7. PubMed ID: 11798768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood stem cell transplantation in children with beta-thalassemia.
    Yesilipek MA; Hazar V; Küpesiz A; Kizilörs A; Uguz A; Yegin O
    Bone Marrow Transplant; 2001 Dec; 28(11):1037-40. PubMed ID: 11781613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two HLA-loci mismatched sibling cord blood transplantation in a severe beta-thalassemia patient].
    Sun X; Liu S; Zhao Z; Hao WG; Guo LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):86-8. PubMed ID: 12667297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
    Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S
    Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of double units unrelated cord blood transplantation in adult patients with hematological malignancies].
    Yin Y; Ren HY; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Wang MJ; Wang LH; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):73-7. PubMed ID: 18681304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation.
    Irfan M; Hashmi K; Adil S; Shamsi T; Farzana T; Ansari S; Panjwani V; Ahmed P; Khan B
    J Pak Med Assoc; 2008 Mar; 58(3):107-10. PubMed ID: 18517111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
    Rabitsch W; Reiter E; Keil F; Malzer R; Leitner G; Fischer G; Dieckman K; Kalhs P; Lechner K; Greinix HT
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S49-52. PubMed ID: 9916635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy and safety of unmanipulated haploidentical peripheral blood stem cell transplantation on hematologic diseases].
    Huang WR; Li HH; Jin XS; Wang SH; Bo J; Zhao Y; Jing Y; Zhu HY; Dou LP; Jia BJ; Wang QS; Gao CJ; Yu L
    Zhonghua Nei Ke Za Zhi; 2013 May; 52(5):390-4. PubMed ID: 23945304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
    Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
    Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.